Cargando…
Response to paper by Douxfils et al. Oestradiol is not the Holy Grail in the quest for the ideal oestrogen therapy
Autores principales: | Bińkowska, Małgorzata, Jakimiuk, Artur, Paszkowski, Tomasz, Pawelczyk, Leszek, Skrzypulec-Plinta, Violetta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10566332/ https://www.ncbi.nlm.nih.gov/pubmed/37829265 http://dx.doi.org/10.5114/pm.2023.131374 |
Ejemplares similares
-
Risk of venous thromboembolism during the use of oral estrogen-progestogen hormone therapies in light of most recent research findings
por: Bińkowska, Małgorzata, et al.
Publicado: (2022) -
Ideal scoring system for acute pancreatitis: Quest for the Holy Grail
por: Juneja, Deven
Publicado: (2022) -
Commentary: The ideal prosthetic valve: The quest for the Holy Grail continues
por: Guariento, Alvise, et al.
Publicado: (2022) -
Position Statement by Experts of the Polish Menopause and Andropause Society on menopausal hormone therapy with an oral combination drug containing oestradiol 1 mg and progesterone 100 mg
por: Bińkowska, Małgorzata, et al.
Publicado: (2021) -
Response to paper by Binkowska et al. Risk of venous thromboembolism during the use of oral estrogen-progestogen hormone therapies in light of most recent research findings. Commentary: Oestradiol is not the holy grail in the quest for the ideal oestrogen therapy
por: Douxfils, Jonathan, et al.
Publicado: (2023)